Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To find all manufacturers of a drug with active DMFs
— CEO, specialty pharmaceutical firm, USA
For research of expired patents on drugs sold in Brazil
— Business analyst, Brazil
To profile life cycle initiatives for branded products
— Head product development group, India
To get expiration dates and other data for high profile prescription drugs
— Public policy researcher, USA
For patent information on specific drug portfolios
— Consultant, USA
Generated: May 26, 2017
| Tradename: | 2 |
| Applicant: | 1 |
| Ingredient: | 1 |
| Patents: | 1 |
| Therapeutic Class: | Respiratory Tract Agents |
| Formulation / Manufacturing: | see details |
| Mechanism of Action | Histamine H1 Receptor Antagonists |
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
CETIRIZINE HYDROCHLORIDE ALLERGY |
cetirizine hydrochloride |
TABLET;ORAL | 077829 | ANDA | Kaiser Foundation Hospitals | 0179-8301 | 0179-8301-01 | 100 TABLET in 1 BOTTLE (0179-8301-01) |
CETIRIZINE HYDROCHLORIDE ALLERGY |
cetirizine hydrochloride |
TABLET;ORAL | 077829 | ANDA | Kaiser Foundation Hospitals | 0179-8302 | 0179-8302-01 | 100 TABLET in 1 BOTTLE (0179-8302-01) |
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Aug 26, 2009 | TE: | RLD: | No | |||||
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Aug 26, 2009 | TE: | RLD: | No | |||||
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Aug 26, 2009 | TE: | RLD: | No | |||||
To be informed abut patent protection and patent challenges
— Business development / Licensing / Marketing & sales, Italy
To find drug patent expiry dates in Europe
— Analyst, Switzerland
For information on selected patent expirations
— Market research, USA
To get reliable data on drug patent information
— CFO, Pharmaceuticals, Singapore
Updates on patents, new and expired; market watch on IP activities
— Formulation development scientist, India
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
